|BioFlux 200 48-well plates, high shear, 0-200 dyn
|BioFlux 200 48-well plates, low shear, 0-20 dyn
|BioFlux 200 48-well custom substrate plate
|BioFlux 200 48-well 0-20 dyn PDMS bottom plates
|BioFlux 200 24-well plates 0-20 dyn
|BioFlux 200 24-well 0-20 dyn PDMS bottom plates
|BioFlux 200 24-well Interface
|BioFlux 200 48-well Interface
|BioFlux Pulsatile Flow Module
|Harness, from controller to vapor trap (old style vapor trap)
|Harness, from vapor (old style) trap to 48-well interface
|Harness, from vapor trap to 24-well interface (old style)
|Filter 0.2 uM luer lock for inside BF controller and vapor trap
|Gasket for 24-well interface
|Gasket for 48-well interface
|Qty 16 0.2 uM replacement filters for BioFlux controller
|Quattro Multiplate adapter for 48-well plates, with heaters. Enables use of up to 4 BioFlux plates in parallel. Includes 3 BioFlux 48 well-plate interface covers and 4 heater bases.
Further accessories on request
During our business hours, our free telephone support will be glad to assist you in case of any questions. Our Technicians take care of the delivery and installation of original spare parts of the highest quality as well as certified testing, measuring, and control equipment. Our maintenance according to manufacturer specifications includes functional tests, cleaning, accuracy testing with calibration as well as a detailed report. In addition, our maintenance contracts protect your investments and reduce the total cost of ownership.
Detailed information about our support options can be found here.
Fluxion Biosciences is located in California and delivers advanced solutions that automate complex cell-based and cell-free assays. Products include ERASE-Seq for NGS analysis of cancer from a "liquid biopsy"blood sample, IsoFlux for circulating tumor cell analysis, BioFlux for functional analysis of cellular interactions, and the IonFlux automated patch clamp system. Hundreds of labs worldwide rely on Fluxion's solutions to research novel biology, accelerate drug discovery, and tailor therapies based on patient-specific biomarkers.
More about Fluxion Biosciences: www.fluxionbio.com